A brand sends the same brief to three plants and gets three prices that differ by nineteen cents a bottle. All three call themselves full service. Six months later the first commercial batch fails assay at the end of shelf life, and the difference between the quotes finally shows up in the file: one of them ran a stability study in the retail pack, the other two ran it in a screw-top glass jar in a stability chamber.
Nobody lied in the quotation. The word "full service" never defined where the service stops.

Five stages and four handovers
Contract manufacturing dietary supplements is sold as one thing and run as five. Formula development. Raw material purchase. Processing. Packing and labelling. Testing and release. Our note on dietary supplement contract manufacturing walks the same five stages from the plant side.
Every one of those stages can be bought on its own, and each boundary between them is a place where responsibility changes hands. A quote that covers all five still hands over four times, and each handover has a document attached: a specification, a purchase order, a batch record, a certificate of analysis. The handover is where projects go wrong, because a document that does not name an owner is a document that nobody has to honour.
The practical test of a full service supplement manufacturer is not how many stages it lists. It is whether the same legal entity is accountable from the first gram of material to the last signature on the release. When the answer is yes, a deviation gets investigated once. When the answer is no, it gets investigated twice and paid for twice.
What the phrase usually leaves out
Three things sit outside most full-service scopes even when the wording suggests otherwise.
The first is stability in the pack you actually sell. A stability study is only evidence about the package it was run in. A gummy in a clear PET jar with a white cap, a foil pouch and a high-density bottle are three different moisture environments, and water activity is what decides whether a pectin piece stays firm or goes leathery at month nine. If the artwork and the jar come from the brand's own supplier, the plant can still run the study, but it cannot make the result apply to a pack it never saw.
The second is the label. A manufacturer can print what it is given and can check that the net quantity, the ingredient list order and the allergen statement are internally consistent. It cannot decide whether a claim is authorised in the destination market, and it should not be asked to. That judgement belongs to whoever is named on the front panel.
The third is market access. Registration of the manufacturing site, notification of the product, import clearance, and the customs classification of a finished supplement are separate transactions with separate authorities. A plant that ships to forty countries has done each of them many times; that experience is useful and it is not the same as doing them for you.
The certificate and what it actually says
A certificate of analysis is the most quoted and least read document in this trade. It should state, for each parameter, the specification, the method, the result and the unit. A line that says "Assay: complies" without a figure is not a result, it is an opinion.
Two questions separate a useful CoA from a decorative one. Is the sampling described, and does the result refer to the batch or to a composite? A composite sample tells you the average of a blend. If your active is 0.4 per cent of the formula, the average is the one number that can be right while individual servings are wrong.
The same document also has to be signed by someone with the authority to hold the batch. On a split chain, that signature is often the weakest link, because the blender tested the powder, the filler tested the capsules, and neither tested the finished, packed, labelled unit that a consumer will open.
Where a split chain actually breaks
Splitting the five stages is a legitimate way to buy, and for some products it is the cheaper one. It breaks in four predictable places.
Retention samples get split with the stages. If the blender keeps powder and the filler keeps capsules, nobody holds a retail unit from the same lot, and a complaint at month twelve cannot be reproduced.
Deviations lose an owner. A colour that shifts during drying could come from the colour supplier, the syrup, the depositor temperature or the curing room. With one entity, that is one investigation. With three, it is three letters and a meeting.
Testing gets paid for twice, or skipped once. Incoming material testing, in-process checks and finished goods testing are three different scopes. A split chain tends to buy the first and the third and assume the middle happens.
Minimum order quantities multiply. Each supplier has its own MOQ per component, and a brand that splits four stages usually discovers it has committed to four times the material it needed.
Who is responsible on the label
In the European Union, Regulation (EC) No 178/2002 puts the responsibility for a food on the food business operator under whose name it is marketed. That is normally the brand, not the plant. The address on the pack can be the brand's office, and the manufacturing site can be a line item elsewhere on the label or in the paperwork.
In the United States, the facility that manufactures, processes, packs or holds the product registers with FDA, and the preventive controls rule under 21 CFR 117 applies to that facility. The importer carries separate obligations under the Foreign Supplier Verification Program. None of that transfers the brand's own responsibility for the label and the claims.
This matters when choosing between a full-service and a split buy, because the entity that takes the risk is the same in both cases. What changes is how many parties have to be coordinated when something goes wrong at two in the morning.
A note on the word GMP, since it appears in every quotation. In the United States, dietary supplements are food and fall under the food GMP in 21 CFR 117. In the European Union there is no supplement-specific GMP regulation; a supplement is a food and follows the hygiene rules of Regulation (EC) No 852/2004 plus the operator's own HACCP-based system. A supplier that says "pharma GMP" is describing a different regime than the one your product will be judged against, and the certificate behind that phrase may not cover food at all.
What the price difference is made of
Two quotes for the same formula and the same 500 kg batch rarely differ because one plant is greedy. They differ on five variables.
Deposit weight and piece count. A three gram piece at 500 kg is about 166,000 pieces. A four gram piece is 125,000. The whole costing moves with that number, because labour, trays, curing time and packaging are counted per batch, not per kilogram.
Test scope. Identity, assay, microbiology, heavy metals, and a stability pull point at zero, three, six and twelve months are five separate purchases. The set changes with the dosage form: a gummy and a two-piece capsule are not tested the same way. Cutting the twelve-month point is the most common way to shave a quotation, and it is the one that shows up as a failed batch a year later.
Pack format. A jar with an induction seal, a stick pack and a blister are three different lines with three different speeds. The pack also decides whether the stability study has to be repeated.
Material grade. The same botanical at a 4:1 ratio and at a 10:1 standardised extract can differ by a factor of ten in price and a factor of two in the powder going into the kettle.
Payment and batch size. A single batch and a twelve-month schedule with monthly calls are not the same commitment, and the price reflects which one the plant is being asked to hold.
When splitting is the better buy
A split chain wins in three situations, and they are specific.
The brand already owns the filling line. Powder blended to specification and shipped in 25 kg foil-lined bags is cheaper per kilogram than the same powder filled, capped, labelled and cased, and the brand keeps control of the pack it has spent money designing. The same logic applies to capsules, where the shell and the fill are two purchases already.
The product is a commodity at volume. A plain multivitamin in a standard bottle does not need development, and buying blending, filling and testing from three specialists can beat a single full-service price.
The pack is unusual. A custom tin, a shaped bottle or a children's format with a novelty closure may need a packaging partner the supplement plant does not have. In that case the plant makes the product and the brand runs the pack, which works as long as somebody owns the stability question in the actual container.
Everywhere else, the coordination cost is real and it lands on the brand. One entity holding the batch record from material receipt to release is worth paying for when the alternative is four signatures and nobody accountable.
Ding Shaohua, Foreign Trade Manager at WANHUACAO, works with brands and distributors on supplement programmes from brief to first shipment, in bulk and in private label, across gummies, capsules, powders and tea. The plant operates under SGS CN23/00007035 for gel confectionery and SC11434160205012 covering eight dosage forms, sports nutrition supplements among them. Reach him on WhatsApp, TikTok, LinkedIn and Facebook.
FAQ
Is full service more expensive than splitting the stages?
Not necessarily per unit, and often not once the hidden costs are counted. A full-service quote bundles coordination, one set of retention samples and one investigation when something drifts. A split buy can be cheaper on paper and more expensive in the month a batch is held, because three suppliers each wait for the other two to answer. The comparison only works when both quotes list the same test scope, the same pack and the same stability points.
Can I keep my own formula with a full-service manufacturer?
Yes, and the agreement should say so explicitly. A formula developed by the brand and handed over remains the brand's, but the plant may own background know-how such as process parameters, and it will usually own the batch records it is legally required to keep. What needs writing down is who may use the formula elsewhere, for how long, and what happens to the technical package if the relationship ends.
Who holds the batch records if production is split across two plants?
Each plant holds the records for the operations it performed, which is exactly the problem. Nobody holds a single record covering the whole lot, so a complaint has to be traced through two document sets that were never designed to be read together. If the stages must be split, agree in advance on a lot numbering scheme that both sites use, and nominate one party to hold retail-unit retention samples.
Does full service include label compliance for my market?
Printing and consistency checking, usually yes. Legal compliance for the destination market, no. The claim wording, the nutrition declaration format and the permitted ingredients differ between the EU, the US, the UK and the Gulf, and the party named on the label is the one accountable for them. A manufacturer can tell you what it has seen pass before; that is experience, not a legal opinion.
